Novartis hopes to develop cheap dengue test
Swiss drugmaker Novartis AG hopes to develop a cheap test to detect dengue fever following the acquisition of vaccine and blood-testing firm Chiron, an executive said.
Thousands of people across Southeast Asia this year have been hit by dengue, a potentially fatal mosquito-borne disease for which there is no vaccine. The disease, which occurs mainly in tropical Asia, Africa and the Caribbean, affects tens of millions of people every year.
Hairdressers at Risk for Occupational Asthma
The bleaching agents used by hairdressers can cause occupational asthma and rhinitis, say researchers here.
The finding comes from an eight-year series study of 47 hairdressers who were referred to the allergy and immunology unit at the Scientific Institute of Pavia here, according to Gianna Moscato, M.D., head of the allergy unit.
